Satellos Bioscience Inc (MSCLF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MSCLF | AZN | AMGN | GILD | VRTX |
| Company | Satellos Bioscience Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.4942 | 91.18 | 321.82 | 121.07 | 442.55 |
| High | 0.4942 | 91.45 | 323.00 | 122.25 | 448.28 |
| Low | 0.4800 | 90.38 | 317.00 | 120.38 | 438.61 |
| Latest | 0.4854 | 90.31 | 316.96 | 119.65 | 439.41 |
| Change | +0.0088 | -0.97 | -4.27 | -1.54 | -2.63 |
| % Change | +1.85% | -1.06% | -1.33% | -1.27% | -0.59% |
| Volume | 44,001 | 821,778 | 443,005 | 592,897 | 144,007 |
| 20-Day Average Volume | 105,690 | 5,314,997 | 2,815,965 | 6,782,659 | 1,352,347 |
| Previous Close | 0.4766 | 91.28 | 321.23 | 121.19 | 442.04 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.5019 | 90.32 | 337.22 | 124.58 | 435.55 |
| 20-Day Raw Stochastic | 26.11% | 48.71% | 0.71% | 18.36% | 48.71% |
| 20-Day Relative Strength | 45.30 | 59.13 | 47.09 | 46.76 | 55.02 |
| Weighted Alpha | -27.85 | +39.32 | +17.27 | +27.81 | -2.15 |
| Today's Opinion | 8% Sell | 100% Buy | 80% Buy | 64% Buy | 24% Buy |
| Previous Opinion | 8% Sell | 100% Buy | 80% Buy | 80% Buy | 24% Buy |
| Last Month's Opinion | 24% Buy | 100% Buy | 56% Buy | 88% Buy | 56% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.76% since 12/02/25 | +0.40% since 12/02/25 | -6.25% since 12/02/25 | -2.80% since 12/02/25 | +1.55% since 12/02/25 |
| Low | 0.4576 on 12/04/25 | 89.67 on 12/08/25 | 317.00 on 12/09/25 | 120.38 on 12/09/25 | 438.61 on 12/09/25 |
| High | 0.5520 on 12/08/25 | 91.43 on 12/09/25 | 346.38 on 12/03/25 | 125.60 on 12/03/25 | 463.85 on 12/03/25 |
| 1-Month | |||||
| %Chg | -4.72% since 11/07/25 | +7.04% since 11/07/25 | -0.93% since 11/07/25 | +1.35% since 11/07/25 | +7.43% since 11/07/25 |
| Low | 0.4419 on 11/14/25 | 85.85 on 11/10/25 | 317.00 on 12/09/25 | 117.13 on 11/10/25 | 410.50 on 11/10/25 |
| High | 0.5878 on 11/17/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 3-Month | |||||
| %Chg | -2.36% since 09/09/25 | +11.47% since 09/09/25 | +13.30% since 09/09/25 | +4.04% since 09/09/25 | +10.95% since 09/09/25 |
| Low | 0.4419 on 11/14/25 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 0.6346 on 10/10/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 6-Month | |||||
| %Chg | +17.47% since 06/09/25 | +24.00% since 06/09/25 | +9.39% since 06/09/25 | +6.58% since 06/09/25 | -1.41% since 06/09/25 |
| Low | 0.3774 on 06/16/25 | 68.61 on 07/21/25 | 267.83 on 06/23/25 | 104.46 on 06/25/25 | 362.50 on 08/11/25 |
| High | 0.6436 on 07/01/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 88,413 | 283,098,176 | 172,976,256 | 150,358,016 | 112,153,952 |
| Shares Outstanding, K | 185,507 | 3,101,426 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 0 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -20,510,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 0 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -5,820,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 1.16 | 0.31 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.03 on 11/14/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 11/12/25 | 11/06/25 | 11/04/25 | 10/30/25 | 11/03/25 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 09/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 11/21/25 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.73 | 15.08 | 14.80 | 29.75 |